CYTOKINETICS INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cytokinetics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Cytokinetics Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $17.1M, a 149% increase year-over-year.
  • Cytokinetics Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $44.1M, a 69.9% increase year-over-year.
  • Cytokinetics Inc annual Nonoperating Income (Expense) for 2023 was $27.6M, a 144% increase from 2022.
  • Cytokinetics Inc annual Nonoperating Income (Expense) for 2022 was $11.3M, a 3327% increase from 2021.
  • Cytokinetics Inc annual Nonoperating Income (Expense) for 2021 was $331K, a 93.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $44.1M $17.1M +$10.2M +149% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $33.9M $11.6M +$4.77M +70.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $29.1M $7.91M +$1.49M +23.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $27.6M $7.59M +$1.67M +28.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $26M $6.84M +$2.7M +65% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $23.3M $6.78M +$5.92M +685% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $17.4M $6.43M +$6.01M +1448% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $11.3M $5.92M +$6.3M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $5.05M $4.14M +$3.91M +1694% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.13M $864K +$677K +362% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $456K $415K +$125K +43.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $331K -$377K -$2.52M -118% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.85M $231K -$847K -78.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $3.7M $187K -$1.2M -86.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $4.9M $290K -$433K -59.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.33M $2.15M +$816K +61.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $4.51M $1.08M +$58K +5.69% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $4.46M $1.38M +$338K +32.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $4.12M $723K -$418K -36.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $4.54M $1.33M +$430K +47.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $4.11M $1.02M -$303K -22.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $4.41M $1.04M -$82K -7.28% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $4.49M $1.14M +$299K +35.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $4.19M $900K +$125K +16.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $4.07M $1.32M +$544K +69.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $3.52M $1.13M +$514K +84% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.01M $842K +$406K +93.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.6M $775K +$591K +321% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $2.01M $779K +$668K +602% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.34M $612K +$505K +472% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $838K $436K +$374K +603% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $464K $184K +$124K +207% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $340K $111K +$72K +185% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $268K $107K +$69K +182% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $199K $62K +$25K +67.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $174K $60K +$38K +173% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $136K $39K +$12K +44.4% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15
Q2 2015 $124K $38K +$5K +15.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $119K $37K +$11K +42.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $108K $22K -$77K -77.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $185K $27K +$4K +17.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $181K $33K +$6K +22.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $175K $26K -$2K -7.14% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $177K $99K +$66K +200% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 $111K $23K -$6K -20.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $117K $27K +$14K +108% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $103K $28K +$16K +133% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $87K $33K +$13K +65% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 $74K $29K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $74K $13K -$2K -13.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $76K $12K -$28K -70% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $104K $20K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-07
Q3 2011 $29K -$19K -39.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $15K +$5K +50% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $40K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $48K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $10K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.